Active, not recruiting
A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa
NCT07174726
- Conditions
- Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, +2 more
- Locations
-
- University of Florida Jacksonville Ophthalmology Jacksonville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States
- Duke Eye Center Durham, North Carolina, United States
- Cincinnati Eye Institute Cincinnati, Ohio, United States